Five pharma companies are represented on the Consumer Health Committee:
|Gemma Codina Tena
||Sanofi Consumer Health
||Pfizer Consumer Healthcare
‘EphMRA Full Members working together to ensure that OTC data and systems provide the most suitable platform for international secondary market research in Consumer Health.
By liaising with suppliers the committee aims to improve existing OTC data and systems in terms of quality and greater transparency of content.’
Committee activities will include:
- Working to build more consistent definitions of OTC data across countries to ease harmonisation with ethical data sources and provide greater analytical flexibility
- Identifying current unmet needs in Consumer Health market research and addressing these with suppliers
The Consumer Health Committee works in close co-ordination with the EphMRA Data & Systems Committee to encourage the establishment of an integrated data picture and ease analysis across OTC and Rx data sets.
The first priority of the Consumer Health Committee has been to liaise with IMS on OTC panel coverage. Currently the committee is working with IMS to gain a comprehensive picture of OTC panel definitions, structure, collection methods and channel coverage and to suggest improvements.
The committee will also be working with IMS to look at OTC classification issues and country-specific issues such as the flagging of Traditional Chinese Medicines in the China panel.
The Consumer Health Committee has also been making contact with other OTC data providers and will be working to inform EphMRA membership on the range of OTC data services available.
The committee would be very pleased to receive enquiries from other Full Members wishing to help improve OTC data sources and systems.
If you would like to contribute, please contact Bernadette Rogers on email@example.com